CIK 0001781983
- Non-accelerated filer
- Smaller reporting company
Aprea Therapeutics, Inc.
Sign in to watch- Ticker
- APRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 215-948-4119
- Business address
- 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-10 | Abrahmsen Lars B. SVP, Chief Scientific Officer | Grant or award | +24,700 | 43,700 | ||
| 2022-03-10 | Abrahmsen Lars B. SVP, Chief Scientific Officer | Grant or award · Stock Option (right to Buy) | +100,000 | 100,000 | ||
| 2021-10-01 | Abrahmsen Lars B. SVP, Chief Scientific Officer | Exercise or conversion | +50,000 | $0.92 | $46K | 69,000 |
| 2021-10-01 | Abrahmsen Lars B. SVP, Chief Scientific Officer | Sale | −50,000 | $4.89 | $245K | 19,000 |
| 2021-10-01 | Abrahmsen Lars B. SVP, Chief Scientific Officer | Exercise or conversion · Stock Option (right to Buy) | −50,000 | 30,587 | ||
| 2021-09-20 | Abrahmsen Lars B. SVP, Chief Scientific Officer | Exercise or conversion | +25,000 | $0.92 | $23K | 44,000 |
| 2021-09-20 | Abrahmsen Lars B. SVP, Chief Scientific Officer | Sale | −25,000 | $4.97 | $124K | 19,000 |
| 2021-09-20 | Abrahmsen Lars B. SVP, Chief Scientific Officer | Exercise or conversion · Stock Option (right to Buy) | −25,000 | 80,587 | ||
| 2021-02-25 | Abrahmsen Lars B. SVP, Chief Scientific Officer | Grant or award | +19,000 | 19,000 | ||
| 2021-02-25 | Abrahmsen Lars B. SVP, Chief Scientific Officer | Grant or award · Stock Option (right to Buy) | +82,000 | 82,000 | ||
| 2020-03-24 | Abrahmsen Lars B. SVP, Chief Scientific Officer | Grant or award · Stock Option (right to Buy) | +31,600 | 31,600 | ||
| 2019-10-07 | Abrahmsen Lars B. SVP, Chief Scientific Officer | Grant or award · Stock Option (right to Buy) | +77,630 | 77,630 |
Page 1 of 1 · 12 trades